Jianzhijia Pharmaceutical Chain Group Co., Ltd.

XSSC:605266 Stock Report

Market Cap: CN¥4.1b

Jianzhijia Pharmaceutical Chain Group Balance Sheet Health

Financial Health criteria checks 3/6

Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.8B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 118%. Its total assets and total liabilities are CN¥10.7B and CN¥7.9B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥417.7M making its interest coverage ratio 3.3. It has cash and short-term investments of CN¥760.6M.

Key information

118.0%

Debt to equity ratio

CN¥3.25b

Debt

Interest coverage ratio3.3x
CashCN¥760.62m
EquityCN¥2.76b
Total liabilitiesCN¥7.95b
Total assetsCN¥10.71b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 605266's short term assets (CN¥4.7B) do not cover its short term liabilities (CN¥5.5B).

Long Term Liabilities: 605266's short term assets (CN¥4.7B) exceed its long term liabilities (CN¥2.4B).


Debt to Equity History and Analysis

Debt Level: 605266's net debt to equity ratio (90.4%) is considered high.

Reducing Debt: 605266's debt to equity ratio has increased from 12.9% to 118% over the past 5 years.

Debt Coverage: 605266's debt is well covered by operating cash flow (25.1%).

Interest Coverage: 605266's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Discover healthy companies